FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (46)	2/7/2000 10:51:00 PM
From: opalapril	Read Replies (1) of 75

Good point, but only if you assume the buy time is intended to be before FDA recommendation or approval. Doesn't hurt to watch them closely as P-3 ends, for example to see if perhaps the company (1) intends to dilute shares with a massive offering; or (2) refuses to release the data to shareholders; or (3) after years of plainly stating the company strategy is to spurn partners until FDA approval of its lead drug, suddenly announces a partnering contract the details of which it also refuses to release. But enough about Xoma. What stock were you going to recommend, George?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next